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NEW FINDINGS 
 
What is the central question of this study? 
Cardiac T-tubules are membrane invaginations essential for the excitation-contraction coupling. 
Imipramine, an antidepressant agent, is a cationic amphiphilic drug which interferes with the 
PI(4,5)P2 interactions with proteins maintaining the tubular system, but its validation as a new 
detubulating tool as not yet been reported. 
 
What is the main finding and its importance? 
We validate imipramine as a more efficient and less toxic detubulating agent of cardiomyocytes, than 
formamide, provide new insights on how PI(4,5)P2 is crucial to maintain T-tubules attached to the 
cell surface and on the cardiotoxic effects of imipramine overdoses. 
 
ABSTRACT 
 
Cardiac T-tubules are membrane invaginations essential for the excitation-contraction coupling 
(ECC). Imipramine like other cationic amphiphilic drugs, interfere with the PI(4,5)P2 interactions with 
proteins maintaining the tubular system connected to cell surface. Our main purpose was to validate 
imipramine as a new detubulating agent in cardiomyocytes. Staining adult rat ventricular myocytes 
(ARVMs) with di-4-ANEPPS, we showed that unlike formamide, imipramine induces a complete 
detubulation with no impact on cell viability. Using the patch-clamp technique, we observed a ~40% 
decrease in cell capacitance after imipramine pretreatment and a reduction of ICa,L amplitude by 
~72%. These parameters were not affected in atrial cells, excluding direct side effects of imipramine. 
The β-adrenergic receptor’s (β-AR) stimulation of the remaining ICa,L with isoproterenol (Iso) was still 
effective. ECC was investigated in ARVMs loaded with Fura-2 and paced at 1 Hz, allowing 
simultaneous measurement of Ca2+ transient (CaT) and sarcomere shortening (SS). Amplitude of 
both CaT and SS was decreased by imipramine and partially restored by Iso. Furthermore, 
detubulated cells exhibited Ca2+ homeostasis perturbations. Real-time cAMP variations induced by 
Iso using a Förster resonance energy transfer (FRET) biosensor revealed a ~27% decreased cAMP 
elevation upon β-AR stimulation.To conclude, we validated a new cardiomyocyte detubulation 
method using imipramine which is more efficient and less toxic than formamide. This antidepressant 
agent induces the hallmark effects of detubulation on ECC and its β-AR stimulation. Besides, we 
provide new insights on how imipramine overdose may affect cardiac function and suggest that 
PI(4,5)P2 is crucial to maintain T-tubules structure. 
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INTRODUCTION 
Transverse tubules (T-tubules) of cardiac myocytes are invaginations of the surface membrane that 
form a complex interconnected network penetrating deep into the cell interior (Hong & Shaw, 2017). 
These tubular structures are found mostly in ventricular myocytes where they occur near the 
sarcomeric z-discs (Caldwell et al., 2014), allowing functional junction with the sarcoplasmic 
reticulum called dyad. They are critical for the excitation-contraction coupling (ECC) by concentrating 
L-type Calcium channels (LTCC) and positioning them at close proximity of ryanodine receptors 
(RyR) clusters at the junction of sarcoplasmic reticulum. During an action potential, T-tubules 
propagate the cell-membrane depolarization inside the cell allowing Ca2+ entry to trigger successive 
Ca2+ release thus promoting synchronicity as well as efficiency of the Ca2+-induced Ca2+ release 
(CICR) phenomenon (Fu et al., 2016). Their enrichment with ion channels and the presence of 
signaling pathways components such as β-adrenergic receptors (β-AR) (Nikolaev et al., 2010) and 
adenylyl cyclases (AC) (Timofeyev et al., 2013) make these structures essential for cardiomyocyte 
function and regulation. Alterations in their morphology and density are believed to take part in the 
development of heart failure (Hong & Shaw, 2017), thus understanding their role is crucial and may 
open new therapeutic avenues.  
To define the role of the T-tubules in the physiology of ventricular cells, the Orchard’s group in the 
late 90’s provided a simple detubulation method. It is based on an osmotic shock induced by a high 
concentration of formamide and its quick removal to disrupt the normal coupling of the membrane 
invaginations with the cell surface (Kawai et al., 1999; Brette et al., 2002). Since then, dozens of 
reports were published using this technique as a gold standard method to detubulate 
cardiomyocytes. However, despite the apparent preservation of the microtubule network (Brette et 
al., 2002), formamide incubation and removal produce drastic changes in cell volume (Kawai et al., 
1999) which may alter subcellular microdomains. Furthermore, although quite efficient, detubulation 
by formamide is incomplete, with ~20% of the cells remaining intact (Kawai et al., 1999; Pasek et 
al., 2008). Additionally, ~80% of the myocytes still exhibit a faint staining of invaginations (Brette et 
al., 2002). More importantly, formamide-induced detubulation is generally variable and more 
importantly is accompanied with the loss of a large proportion of viable cells which is especially 
prejudicial when performed on cardiac cells isolated from valuable pathological or genetically 
modified models. Therefore, an alternative treatment which would be more efficient and less toxic 
would be useful for cardiac physiologists. Interestingly, a recent study demonstrated that high 
concentrations of cationic amphiphilic drugs (CADs) can produce detubulation of adult rat ventricular 
myocytes (ARVMs) probably by interfering with PI(4,5)P2 interactions with cytoskeletal and BAR 
(Bin-Amphiphysin-Rvs) domain containing proteins (Osman et al., 2016). However, a comparison of 
this detubulation method with the formamide-induced removal of T-tubules has not yet been 
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performed and the consequences on CICR or β-AR signaling of the detubulation induced by CADs 
binding to PI(4,5)P2 in ventricular myocytes are unknown. Our aim here was therefore to provide 
these informations. To do so, we selected one of the CADs causing cardiomyocyte detubulation, an 
antidepressant agent named imipramine (Osman et al., 2016).  
METHODS 
Ethical approval 
All experiments were carried out according to the European Community guiding principles in the care 
and use of animals (2010/63/UE, 22 September 2010), the local Ethics committee (CEEA26 
CAPSud) guidelines and the French decree n°2013-118, 1st February 2013 on the protection of 
animals used for scientific purposes (JORF n°0032, 7 February 2013 p2199, text n°24). Animal 
experiments were approved by the French Ministry of Agriculture (prefectural agreement N°2016-
108 and agreement to our animal facility N° C 92-019-01). Rats had ad libitum access to water and 
standard rat chow and were housed in a well‐ventilated, specific pathogen‐free, temperature‐
controlled environment to ensure that animals were not under stress. Enrichment was added in 
animal cages. 
Reagents 
Isoproterenol from Sigma-Aldrich (Saint-Quentin, France) was prepared in a 1 mg/mL ascorbic acid 
solution at 10 mM (Sigma-Aldrich, Saint-Quentin, France). Di-4-ANEPPS (Pyridinium, 4-(2-(6-
(dibutylamino)-2-naphthalenyl)ethenyl)-1-(3-sulfopropyl)-, hydroxide), formamide and imipramine 
were from Sigma-Aldrich, Saint-Quentin, France). 
Cardiomyocyte isolation and culture 
Male Wistar rats (250–300 g) were anesthetized by intraperitoneal injection of pentobarbital (0.1 
mg/g) and hearts were excised rapidly. Individual ARVMs were obtained by retrograde perfusion of 
the heart as previously described (Mika et al., 2013). For enzymatic dissociation, the hearts were 
perfused at a constant flow of 6 mL/min at 37 °C with a Ca2+-free Ringer solution containing (in mM): 
NaCl 117, KCl 5.7, NaHCO3 4.4, KH2PO4 1.5, MgCl2 1.7, D-glucose 11.7, Na2-phosphocreatine 10, 
taurine 20, and 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) 21, pH 7.1 during 5 
min, followed by a perfusion at 4 mL/min for 40 min with the same solution containing 1 mg/mL of 
collagenase A (Roche Diagnostics GmbH, Mannheim, Germany) plus 300 µM ethylene glycol 
tetraacetic acid (EGTA) and CaCl2 to adjust free Ca2+ concentration to 20 µM. The ventricles and 
atria were then separated, finely chopped and gently agitated to dissociate individual cells from each 
tissue. The resulting cell suspension was filtered on gauze and the cells were allowed to settle down. 
The supernatant was discarded and cells resuspended four more times with Ringer solution at 
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increasing [Ca2+] from 20 to 300 µM. Freshly isolated cells were suspended in minimal essential 
medium (MEM: M 4780; Sigma, St Louis, MO, USA) containing 1.2 mM [Ca2+] supplemented with 
2.5% foetal bovine serum (FBS, Invitrogen, Cergy-Pontoise, France), 1% penicillin–streptomycin (P-
S), 20 mM HEPES (pH 7.6), and plated on 35 mm, laminin-coated (10 mg/mL) culture dishes at a 
density of 104 cells per dish and kept at 37°C (0.5% CO2). After 1 h, the medium was replaced by 
300 µL of FBS-free MEM. To perform FRET imaging, the medium was replaced by 300 μL of FCS-
free MEM or transduced with an adenovirus encoding the Epac-SH187 FRET-based sensor 
(Klarenbeek et al., 2015) at a multiplicity of infection (MOI) of 1000 pfu/cell and cells were cultured 
for 24h prior to the experiments. All patch-clamp and IonOptix experiments were performed on 
freshly isolated cardiomyocytes after at least 1h FBS deprivation.  
Electrophysiological experiments 
The whole cell configuration of the patch-clamp technique was used to record ICa,L. Patch electrodes 
resistance between 0.5–1.5 M when filled with internal solution containing (in mM): CsCl 118, 
EGTA 5, MgCl2 4, Na2-phosphocreatine 5, Na2ATP 3.1, Na2GTP 0.42, CaCl2 0.062 (pCa 8.5), 
HEPES 10, adjusted to pH 7.3. External Cs+-Ringer solution contained (in mM): NaCl 107.1, CsCl 
20, NaHCO3 4, NaH2PO4 0.8, D-glucose 5, sodium pyruvate 5, HEPES 10, MgCl2 1.8, CaCl2 1.8 
adjusted to pH 7.4. The cells were depolarized every 8 s from –50 mV to 0 mV during 400 ms. The 
junction potential was adjusted to give zero current between pipette and bath solution before the 
cells were attached to obtain a tight gigaseal (>1GΩ). Cell capacitance was obtained by fitting the 
transient portion of the current response to a 5 mV pulse from -80 mV with a single exponential and 
calculated from the exponential and the area under the curve obtained. The use of –50 mV as holding 
potential allowed the inactivation of voltage-dependent sodium currents. Currents were not 
compensated for capacitance and leak currents. The amplitude of ICa,L was measured as the 
difference between the peak inward current and the current at the end of the depolarization pulses. 
The current-voltage relationship and steady-state inactivation properties were measured by applying 
a 200 ms pulse varying from -60 to +60 mV, followed by a 3 ms repolarization to -50 mV before the 
200 ms test pulse to 0 mV. The current density-voltage (I-V) relationships were fitted with a modified 
Boltzmann equation as follows: I=Gmaxx(V-Vrev)/(1+exp(-(V– V0.5,act)/k)), where I is the current density 
(in pA/pF), Gmax is the maximum conductance (in nS/pF), Vrev is the reversal potential (in mV), V0.5,act 
is the midpoint voltage for current activation (in mV), and k is the slope factor (in mV). Steady-state 
inactivation curves were obtained by normalizing the peak current at each test potential to the 
maximal current, and fitted with a Boltzmann equation: I/Imax = (1−A)/{1+exp[(V−V0.5, inact)/k]}+A, 
where V0.5,inact is the potential of half-maximal inactivation, k is the slope factor, A is the amplitude of 
the non-inactivating ICa,L current. The cells were voltage-clamped using patch-clamp amplifiers: either 
a RK-400 (Bio-Logic, Claix, France) or an Axopatch 200B patch clamp amplifier (Axon Instruments, 
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Inc., Union City, CA, USA). Currents were analogue filtered at 5 KHz and digitally sampled at 10 
KHz using a 16-bit analogue-to-digital converter (DT321; Data translation, Marlboro, MA, USA or a 
digidata 1440A, Axon Instruments) connected to a PC (Dell, Austin, Texas, USA). 
 
Measurements of Ca2+ transients and sarcomere shortening 
All experiments were performed at room temperature. Isolated ARVMs were loaded with 1 µM Fura-
2 AM (Invitrogen) and pluronic acid (0.012%, Molecular Probes) for 15 min in a Ringer solution 
containing (in mM): KCl 5.4; NaCl 121.6; Na-pyruvate 5; NaHCO3 4.013; NaH2PO4 0.8; CaCl2 1.8; 
MgCl2 1.8; glucose 5 and HEPES 10 (pH 7,4 with NaOH). Sarcomere shortening and Fura-2 ratio 
(measured at 512 nm upon excitation at 340 and 380 nm) were simultaneously recorded in Ringer 
solution, using a double excitation spectrofluorimeter coupled with a video detection system 
(IonOptix, Milton, MA, USA). Myocytes were electrically stimulated with biphasic field pulses (5 V, 4 
ms) at a frequency of 1 Hz as previously described (Mika et al., 2013). Ca2+ transient amplitude was 
measured by dividing the twitch amplitude (difference between the end-diastolic and the peak 
systolic ratios) by the end-diastolic ratio, thus corresponding to the percentage of variation in the 
Fura-2 ratio. Similarly, sarcomere shortening was assessed by its percentage of variation, which is 
obtained by dividing the twitch amplitude (difference between the end-diastolic and the peak systolic 
sarcomere length) by the end-diastolic sarcomere length. Relaxation kinetics were estimated by a 
non-linear fit of the decaying part of the Ca2+ transient and sarcomere shortening traces with the 
following equation: X(t)=A*exp(-(t-t0)/))+A0, where t0 is zero time, A0 the asymptote of the 
exponential, A the relative amplitude of the exponential, and  the time constant of relaxation. The 
maximum first derivative of transients during the deflexion allowed to determine the rising velocities 
of the signals. All parameters were calculated offline on a dedicated software (IonWizard 6×, 
IonOptix®). 
FRET imaging 
FRET experiments were performed at room temperature 24h after cell plating. Cells were maintained 
in a Ringer solution containing (in mM): NaCl 121.6, KCl 5.4, MgCl2 1.8; CaCl2 1.8; NaHCO3 4, 
NaH2PO4 0.8, D-glucose 5, sodium pyruvate 5, HEPES 10, adjusted to pH 7.4 (with NaOH). Images 
were captured every 5 s using the 40x oil immersion objective of a Nikon TE 300 inverted microscope 
connected to a software-controlled (Metafluor, Molecular Devices, Sunnyvale, CA, USA) cooled 
charge coupled (CCD) camera (Sensicam PE, PCO, Kelheim, Germany). Cells were excited during 
150-300 ms by a Xenon lamp (100 W, Nikon, Champigny-sur-Marne, France) using a 440/20BP filter 
and a 455LP dichroic mirror. Dual emission imaging was performed using an Optosplit II emission 
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splitter (Cairn Research, Faversham, UK) equipped with a 495LP dichroic mirror and BP filters 
470/30 (CFP) and 535/30 (YFP), respectively. Spectral bleed-through into the YFP channel was 
subtracted using the formula: YFPcorr=YFP-0.6xCFP. The concentration-effect curves of Iso on 
cAMP levels were fitted using the equation Y=A+(Emax-A)/(1+10^((LogEC50-X))) were EC50 is the 
apparent potency, Emax the maximal effect of the agonist, A the minimal % CFP/YFP ratio measured. 
 
Detubulation of ventricular myocytes  
Detubulation was achieved either by inducing osmotic shock with the control solution used for the 
different experiments (external Cs+-Ringer solution prior to patch-clamp or Ringer solution used for 
Ca2+ transient measurement and FRET imaging) containing formamide (1.5 M) for 15 min as 
described previously (Kawai et al., 1999; Brette et al., 2002) or by preincubating the cells with control 
solutions containing 300 µM of imipramine for 15 min followed by washout of the CAD. 
T-tubule imaging 
After plating on laminin, myocytes were bathed for 5 minutes in a Ringer solution and loaded with 
the lipophilic membrane marker Di-4-ANEPPS (2 μM in a Ringer solution for 10 min). After washout, 
T-tubules were examined by using a confocal microscope (TCS SP8, Leica Microsystems, Wetzlar, 
Germany) with a 63X NA 1.20 water immersion objective and the pinhole set to 1 Airy unit. Di-4-
ANEPPS was excited at 478 nm and fluorescence collected between 500 and 750 nm.The center 
image from each cell was selected for a thresholding analysis using a ImageJ plugin described 
previously (Heinzel et al., 2002). T-tubules quantification was performed using the ImageJ free 
software. Images were filtered with a despeckle filter and a median filter, after the background was 
subtracted with the rolling ball algorithm. The image was then binarized using an auto local threshold, 
with the Bernsen method (Autothreshold plug-in). The contrast threshold parameter was visually 
adjusted to ensure the coherence of the binarized image with the original one. A region of interest 
was defined inside the cell excluding the plasma membrane then a percent area was calculated. 
This value corresponds to the ratio of the number of white pixels over the size of the region multiplied 
by 100 and thus, constitutes an index of the T-tubules density. 
Statistical analysis 
All results are expressed as mean±SD. Statistical analysis was performed using GraphPad Prism 
software (GraphPad software, Inc., La Jolla, CA, USA). Normal distribution was tested by a Shapiro-
Wilk normality test. For normally distributed data, an unpaired t-test was performed. We performed 
unpaired t-test to determine statistical significance between two groups. Because the data obtained 
did not follow a normal distribution, a Kruskal-Wallis followed by a Dunn’s post hoc test was used to 
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analyse differences between multiple groups. A Chi2 test followed by a Fischer exact test was used 
when appropriate. The F-test for model discrimination was used to analyse differences between the 
concentration-effect curves. Differences with P-values <0.05 were considered as statistically 
significant. The number of independent experiments performed is indicated in the figure legends. 
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Results 
Imipramine is more efficient and less toxic than formamide to detubulate adult rat ventricular 
myocytes 
Our initial experiments were designed to examine the structure of the t-tubular system in control and 
adult rat ventricular myocytes treated with either imipramine or formamide, in order to compare the 
respective ability of these compounds to produce detubulation. To do so, we stained cell membrane 
with the lipophilic fluorescent dye Di-4-ANEPPS. Using confocal microscopy, we visualized the 
indicator which highlighted the cell surface on the periphery and T-tubules in the center of control 
cells (Figure 1A). We then calculated the percentage of the cell interior occupied by membranes 
accessible to staining to approximate the T-tubules’ density. It represented about 20% of the surface 
of the control cardiomyocytes (Figure 1B, n=34). In contrast, T-tubules were absent in cells treated 
with imipramine (n=32, p<0.001 versus control) while in formamide-treated cells, these invaginations 
were indeed decreased (n=35, p<0.001 versus control) but still covered 6% of the total measured 
area to remain more abundant than in imipramine treated cells (Figure 1B, p<0.01). Thus, osmotic 
shock induces partial detubulation while imipramine removes completely the T-tubular system. 
Furthermore, formamide treatment severely damaged the cell structure, with only ~40% of the cells 
conserving a rod-shaped appearance while imipramine had no obvious impact on cell morphology 
(Figure 2A and B, p<0.001 versus formamide). These results suggest that unlike imipramine, the 
osmotic shock induced by formamide damages the cells with a large proportion dying upon 
treatment. Similarly to what has been described with formamide (Brette et al., 2002), detubulation 
induced by imipramine remained 2 hours after treatment (data not shown), indicating that it is not 
reversible (Osman et al., 2016) at least within this time frame. Additionally, when Di-4-ANEPPS was 
incubated prior to imipramine treatment, a striated pattern remained within the cardiomyocyte (data 
not shown). Thus, with imipramine, T-tubules form vacuoles detached from the sarcolemma within 
the cell as observed following the osmotic shock evoked by formamide (Brette et al., 2002).  
Imipramine decreases cell capacitance and ICa,L amplitude in adult rat ventricular mycocytes 
but not in atrial cells 
Using the patch-clamp technique in the whole cell configuration, we observed a diminution of cell 
capacitance from 184.2±10.8 pF (n=21) to 105.2±6.3 (n=20; p<0.01) in cells subjected to imipramine 
(Figure 3A), indicating a loss of nearly 40% of total membrane. A double-pulse protocol allowed to 
test biophysical properties of the L-type Ca2+ current recorded in control cells or in cardiomyocytes 
pretreated with imipramine (Figure 3B and C). ICa,L maximal amplitude measured at 0 mV decreased 
by ~72% from 1528.7±30.4 pA to 432.2±11.9 pA in detubulated cells confirming enrichment of 
channels within the T-tubules. Half activation potential was depolarized after imipramine treatment 
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from -13.8±0.9 mV (n=21) in control to -8.9±1.5 mV (n=20, p<0.01) suggesting altered gating of the 
channels remaining in the sarcolemma. As expected, reversal potential remained unchanged at +59 
mV in all tested conditions. In cells treated with imipramine, half steady-state inactivation potential 
was slightly but significantly shifted towards negative potentials from -24.9±0.2 mV to -26.9±0.3 mV 
(n=20-21, p<0.01). Furthermore, in accordance with less Ca2+ dependent inactivation (Argibay et al., 
1988), at potentials more positive than +20 mV, ICa,L elicited by the test pulse became progressively 
larger in cells treated with the antidepressant agent (Figure 3C).  
Because the majority of adult rat atrial cardiomyocytes lack t-tubule invaginations (Brette et al., 2002; 
Smyrnias et al., 2010), we tested the effect of imipramine in these cells for potential side effects. 
Besides, this allowed us to test whether the diminution of ICa,L amplitude recorded in imipramine 
treated ventricular cardiomyocytes could be the consequence of its known inhibitory effect on cardiac 
ICa,L at µM concentration (Isenberg & Tamargo, 1985). Unlike in ARVMs, preincubation of atrial 
myocytes with imipramine followed by washout caused a small but non-significant effect on 
membrane capacitance (Figure 4A). Furthermore, imipramine preincubation had no significant effect 
on either amplitude or voltage dependence of ICa,L in atrial cells (Figure 4B). These results indicate 
that a 15 min exposure of cardiomyocytes to the cationic amphiphilic drug followed by washout has 
no direct effect on cell membrane nor on LTCCs.  
To determine whether the β-AR stimulation of ICa,L was affected by imipramine preincubation, ARVMs 
were subjected to an application of a submaximal concentration of isoproterenol (Iso, 3 nM) and the 
current recorded using the double-pulse protocol allowing to compare the effect of the non-selective 
β-AR agonist on biophysical properties of the channels in control and detubulated cells (Figure 5A). 
Maximal conductance (Gmax) was increased from 0.16±0.01 pS (n=21) up to 0.21±0.01 pS (n=15, 
p<0.001) in control cells, leading to a 36% increase of ICa,L density at 0 mV (n=15, p<0.01) (Figure 
5B). Similarly, in detubulated cells, Gmax was increased from 0.08±0.01 pS (n=20) to 0.13±0.01 pS 
by Iso (n=15, p<0.01) and ICa,L density at 0 mV increased by 22% (n=15, p<0.01) (Figure 5B). The 
difference observed on ICa,L amplitude elicited by the test pulse in cells treated with imipramine was 
abolished upon Iso treatment and the half inactivation potential remained hyperpolarized at -26.5±0.3 
mV in imipramine treated cells (n=15, p<0.01) compared to -24.5±0.2 mV measured in non-treated 
cells (Figure 5C). 
Effect of imipramine treatment on Ca2+ transients and contraction of adult rat ventricular 
myocytes 
To test the consequences of detubulation induced by imipramine on ECC, we recorded calcium 
transients (CaT) and sarcomere shortening (SS) simultaneously in cells loaded with 1 µM Fura-2 
and paced at 1 Hz in control conditions and upon β-adrenergic stimulation (Iso, 3 nM) (Figure 6A). 
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Cells pre-incubated with imipramine had an average diastolic sarcomere length of 1.80±0.01 µm 
(n=14) slightly but significantly increased compared to that of control ARVMs 1.68±0.02 µm (n=14, 
p<0.001). The cationic amphiphilic drug drastically decreased mean CaT amplitude from 30.4±1.6% 
(n=15) above diastolic Fura-2 ratio in control cells to 8.2±2.6% (n=14, p<0.001) (Figure 6B). SS was 
9.7±1.3% of diastolic sarcomere length (n=15) in control ARVMs and was also diminished by the 
imipramine pre-treatment (2.3±1.3%, n=14, p<0.05) (Figure 6B). In control cells, CaT and SS 
declined to diastolic levels with average time constants () of 0.18±0.01 s and 0.08±0.01 s 
respectively (n=15). Decline of CaT was slowed in imipramine treated cells (=0.29 ± 0.03 s, n=14) 
as well as relaxation kinetics (=0.43 ± 0.13 s, n=14, p<0.001) (Figure 6C). Strikingly, imipramine 
decreased the rise velocity of CaT from 35.8±6.6 ratio unit/s (n=15) to 10.8±3.15 ratio unit/s (n=14, 
p<0.01) and of SS from 2.4±0.3 µm/s (n=15) to 3.9±0.3 µm/s (n=14, p<0.01) (Figure 6D).  
In control myocytes, application of a submaximal concentration of Iso (3 nM) slightly increased CaT 
amplitude and accelerated Ca2+ return to diastolic levels (=0.1±0.01 ratio unit/s, n=15, p<0.001; 
Figure 6B and C). Upon Iso, a tendency for acceleration of the rising phase of CaT was observed 
(57.6±10.3 ratio unit/s, n=15; Figure 5D). The β-AR stimulation produced inotropic effects, increasing 
SS to 15.9±1.2% (n=15, p<0.05) and slight but not significant lusitropic effects (Figure 6B and C). In 
cells pre-treated with imipramine, Iso increased CaT amplitude ~2.3-fold (n=14, p<0.05) which 
remained significantly decreased compared to CaT recorded in control cells exposed to Iso (Figure 
6B, n=14, p<0.05). Noticeably, in imipramine treated cells, while Iso increased the rise velocity of SS 
(n=15, p<0.01) similarly to what was observed in Crtl cells (n=14, p<0.05), it failed to speed up the 
onset of CaT. However, as expected, the decay of CaT became ~3 times faster (n=14, p<0.0001) 
and SS relaxation increased 6-fold (n=14, p<0.01) to become similar to those of control cells upon 
β-AR stimulation (Figure 6C). Another striking effect of imipramine pre-treatment was to favor Ca2+ 
perturbances (Figure 6E). While we did not observe spontaneous Ca2+ activities in control cells 
neither under basal conditions nor upon Iso, more than 40% of the detubulated cells with the 
antidepressant agent exhibited pro-arrhythmic events (n=15, p<0.01), a proportion reaching nearly 
80% upon β-AR stimulation (n=14, p<0.0001 versus control cells in Iso). 
Effect of Imipramine treatment on intracellular cAMP levels produced upon a β-adrenergic 
stimulation in adult rat ventricular myocytes 
Next, we compared cAMP levels in control ventricular cardiomyocytes and in cells subjected to 
imipramine pretreatment by overexpressing the FRET-based sensor Epac-SH187 (Klarenbeek et al., 
2015) in ARVMs using a recombinant adenovirus. As shown in Figure 6A, in a control cell, a brief 
application of Iso (15 s, 100 nM) increased transiently the CFP/YFP ratio. The mean variation of 
FRET ratio produced by Iso in control cells was 78.9±6.2 % (n=11) and this was reduced by 27.8% 
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in cells subjected to imipramine (n=11, p<0.01) (Figure 6B), without any significant alteration in the 
time course of the signals. We next subjected cells to sustained increasing concentrations of Iso 
from 1 nM up to 300 nM (Figure 6C). The FRET ratio increased in both conditions, but the plateau 
value was decreased in detubulated cells (n=17-28, p<0.001). While apparent potency (EC50) 
remained identical (EC50 was 19.6±6.0 nM in control versus 18.3±6.8 nM in imipramine), the maximal 
effect of Iso was reduced from 105.7±0.1% to 76.9±1% by imipramine. Thus, from these results we 
can conclude that detubulation with a high concentration of the antidepressant agent imipramine 
diminishes by ~27% the cAMP production, suggesting that the majority of cAMP production upon a 
non-selective β-AR stimulation occurs outside the T-tubules.  
 
DISCUSSION 
 
Detubulation of ventricular myocytes with imipramine 
Our study confirms that imipramine disrupts T-tubules from the surface membrane, and thus can be 
used as a new detubulating agent. This new method presents several advantages compared to 
formamide treatment: First, the cells conserve their rod shape after imipramine pretreatment, 
suggesting that unlike the detubulation evoked by an osmotic shock, imipramine-induced 
detubulation preserves cell viability. Additionally, this new detubulation method is more efficient since 
we did not observe tubular system staining with Di-4-ANEPPS after imipramine treatment while we 
observed that the interior of the surviving cells after formamide treatment still exhibited few tubules 
as shown previously (Kawai et al., 1999). More efficient detubulation is further suggested by the 
~40% decreased cell capacitance, which is higher than the 26 to 30% diminution produced by 
formamide in ARVMs that was reported previously (Kawai et al., 1999; Brette & Orchard, 2006; 
Brette et al., 2006; Bryant et al., 2014). Furthermore, this diminution better approximates the T-
tubular membrane fraction (~49%) predicted by computer modeling (Pasek et al., 2008). Besides, 
since the majority of adult rat atrial myocytes lack T-tubules (Brette et al., 2002; Smyrnias et al., 
2010) the absence of a significant effect on cell capacitance allows to exclude any direct effect of 
imipramine on cell membrane other than detubulation. Another advantage of this new method is that, 
unlike formamide, imipramine does not detubulate cardiomyocytes by producing an acute osmotic 
shock, which induces cell volume changes (Kawai et al., 1999) known to evoke electrical remodeling 
(Ravens, 2003) and signaling pathways activation (Gonano et al., 2014). Imipramine is a tricyclic 
antidepressant which contains a hydrophobic ring structure and a hydrophilic side chain with a 
charged cationic amine group, hence it is part of the class term CADs. CADs are one of the largest 
classes of pharmaceutical compounds and these drugs are known to accumulate at the internal 
leaflet of cell membranes (Sheetz & Singer, 1974), where they bind to the negative charges of 
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PI(4,5)P2 via their cationic amine group (Halliwell, 1997). Therefore it constitutes an alternative to 
the drastic osmotic shock produced by formamide to detubulate cells, interfering with the binding of 
the phospholipid to BAR domain containing proteins (Suetsugu et al., 2014). However, it is worth 
noticing that it may interfere with many cellular functions since PI(4,5)P2 not only is crucial for 
membrane tubulation (Inaba et al., 2016; Hofhuis et al., 2017), but is an actor in endocytosis, 
exocytosis (Suetsugu S, et al., 2014), regulates ion channels (Royal et al., 2017) and is involved in 
Ca2+ signaling and intracellular pathways (Berridge, 2009). In ventricular myocytes, the bridging 
integrator 1 (BIN1) is likely to interact with PI(4,5)P2 because it contains a BAR domain and thus, 
may allow the correct folding of the T-tubules and formation of the dyad (Hong et al., 2014; Fu et al., 
2016). However, it is probably not the sole phospholipid binding protein playing this role in heart 
since dysferlin, which recruits PI(4,5)P2 to shape the t-tubule system in skeletal muscle (Hofhuis et 
al., 2017), is also expressed in the heart (Han et al., 2007) where it may also participate in such 
architectural organization. The role of PI(4,5)P2 in the scaffolding of T-tubules of cardiac cells is 
further supported by our results which demonstrate that a CAD disconnects these invaginations from 
surface cell membranes. Interestingly, phospholipids are altered in pressure overload hypertrophied 
hearts (Reibel et al., 1986), in myocardial infarction (Nasa et al., 1997), in the cardiac tissue from 
mice treated with doxorubicin (Moulin et al., 2015) or catecholamines (Emilsson & Gudbjarnason, 
1981). Thus, decreased PI(4,5)P2 within membranes may constitute a link with the decreased density 
of these invaginations in heart failure (Hong & Shaw, 2017), an hypothesis which requires further 
work but is supported by our present results. 
Effects of imipramine pretreatment on ECC in ventricular myocytes  
While detubulation of cells with imipramine reduced by ~40% cell capacitance, we observed a ~72% 
decrease of ICa,L amplitude similar to the diminution by 60 to 76% of ICa,L previously recorded after 
formamide treatment (Kawai et al., 1999; Brette et al., 2006; Bryant et al., 2014). This is in line with 
an enrichment of the T-tubules with LTCCs (Kawai et al., 1999). and suggests that T-tubules 
concentrate ~4 times more channels than the rest of the membrane; this is less than previously 
estimated, probably due to previous underestimation of cell capacitance using formamide (Kawai et 
al., 1999; Pasek et al., 2008). Imipramine is well known to inhibit ICa,L in cardiac cells and this effect 
was demonstrated to be reversible even at µM concentrations (Isenberg & Tamargo, 1985). The lack 
of effect on ICa,L amplitude or its voltage dependence when measured in atrial cells indicates that the 
direct effect of imipramine on the channel was fully reversed after washout of the drug during our 
detubulating procedure. This also confirms that the decreased Ca2+ entry measured in ventricular 
cells is due to an effective loss of channels concentrated within the invaginations. Interestingly, ICa,L 
activation was significantly shifted toward depolarized voltages after detubulation. This is compatible 
with channels being more tightly regulated by PKA in T-tubules (Brette et al., 2004a) where caveolin-
 14 
 
3 facilitates basal activity of the kinase (Timofeyev et al., 2013; Bryant et al., 2014) and the 
localization of LTCCs (Bryant et al., 2018). Besides, voltage dependence of steady-state inactivation 
was shifted towards negative potentials, suggesting differential regulation of surface membrane and 
T-tubule CaV1.2 channels. This may occur via specific association with different variants of auxiliary 
subunits such as β or α2-δ which modulates inactivation of LTCCs (Shaw & Colecraft, 2013). 
Furthermore, at positive potentials, the degree of ICa,L inactivation which correlates with the Ca2+ 
dependent-inactivation (Argibay et al., 1988) was less pronounced in detubulated cells. This is in 
accordance with less negative feedback of Ca2+ released from the SR on channels in the 
sarcolemma (Brette et al., 2004b) and the decreased transient amplitude we observed in myocytes 
pretreated with imipramine. Imipramine pretreatment diminished by two-thirds CaT amplitude and 
thus decreased SS. This is equivalent to the previously reported ~70% decreased CaT amplitude 
induced by formamide detubulation (Kawai et al., 1999; Brette et al., 2002; Brette et al., 2004b) and 
is probably due to the decreased Ca2+ entry in the cardiomyocyte and decreased SR Ca2+ load in 
detubulated cells (Brette et al., 2005). Furthermore, the rise velocity of CaT was impaired and 
detubulated cells exhibited spontaneous CaT and Ca2+ alternans confirming that the T-tubules are 
critical to ensure normal and rapid, synchronized Ca2+ release (Brette et al., 2002; Brette et al., 2005; 
Oyehaug et al., 2013; Caldwell et al., 2014; Frisk et al., 2016). Moreover, the tendency to decreased 
rate decline of CaT in imipramine treated cells is compatible with decreased Na+-Ca2+ exchange 
proteins known to localize in the T-tubules (Kieval et al., 1992; Despa et al., 2003) and decreased 
SERCA2 activity pumping Ca2+ back to the SR due to diminished Ca2+ concentration gradient. 
Altogether, our results demonstrate that the cells pretreated with imipramine exhibit the characteristic 
features of detubulated cells.  
Effect of imipramine on β-adrenergic cAMP signaling and regulation of the ECC 
FRET imaging revealed a ~27% decrease of intracellular cAMP levels elicited by brief or sustained 
non-selective β-AR stimulation in imipramine treated cells. This diminution is in line with decreased 
cAMP production sites by detubulation, due to the loss of β-AR and AC present in the tubular system 
(Nikolaev et al., 2010; Timofeyev et al., 2013). The rather low impact of detubulation on β-AR-
generated cAMP might result from the fact that upon Iso application, cAMP mainly emanates from 
sarcolemal β1-ARs which produce highly diffusible signals throughout the cell (Nikolaev et al., 2010), 
on the contrary to the β2-ARs which resides within the invaginations (Nikolaev et al., 2010; Timofeyev 
et al., 2013). Furthermore, the recovery of cAMP signals which depends on phosphodiesterase 
activities (Leroy et al., 2008) was not impacted by detubulation. This is probably due to the fact that 
the enzymes remained attached to the vacuoles disconnected from the sarcolemma after imipramine 
treatment (data not shown). Consequently, the non-selective β-AR stimulation in detubulated cells 
still increases ICa,L because the majority of the LTCC at the surface membrane are still coupled to β1-
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AR/AC (Timofeyev et al., 2013). As a result, Iso was able to restore CaT amplitude, thus contraction 
by increasing not only Ca2+ entry but probably also SR Ca2+ load by promoting the PKA 
phosphorylation of phospholamban and consequently SERCA2 activity, which remains in 
detubulated cells with formamide (Brette et al., 2004a). The noticeable lusitropic effects we observed 
upon Iso application suggests that it is also the case in imipramine treated cells. However, the rise 
velocity of CaT was not augmented by Iso in detubulated cells, on the contrary to what was reported 
in myocytes treated with formamide (Brette et al., 2004a). This discrepancy might be due to the 
incomplete detubulation following the osmotic shock while imipramine removes totally the tubular 
system. Furthermore, imipramine cells also exhibited Ca2+ homeostasis perturbations upon Iso, 
further underlying the crucial role of T-tubules to obtain rapid and synchronized CICR, even upon β-
AR stimulation. 
CONCLUSIONS 
Although the concentration of imipramine we used here to detubulate cardiomyocytes is much higher 
than the plasmatic levels reached with therapeutic doses (~1 µM), our results suggest that a 
disorganization of T-tubules may contribute to the clinical cardiotoxic effects of the antidepressant 
drug, especially upon overdoses (Marshall & Forker, 1982). Indeed it can evoke heart failure in dog 
(Lucas CM et al., 1992) and intoxication with this TCA has been associated to cardiac arrhythmias, 
depression of myocardial contractility, hypotension and cardiac arrest (Marshall & Forker, 1982) 
which might have been caused at least partly, by the detubulation of the cardiomyocytes. 
Furthermore, besides providing new potential insights into the cardiotoxicity of high doses of 
imipramine, our results validate a new alternative detubulation technique of cardiomyocytes using 
an agent which is known to interfere with PI(4,5)P2. This method is more efficient than the osmotic 
shock induced by formamide and importantly has no impact on cell viability but allows to recapitulate 
the hallmarks of detubulation on ECC. Thus, we propose imipramine as a novel utensil in the toolbox 
of cardiac physiologists who aim to study the role of T-tubules in cardiac cells. 
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FIGURE LEGENDS 
Figure 1. Imipramine is more potent than formamide to detubulate adult rat ventricular 
myocytes. (A) Representative confocal images of adult rat ventricular myocytes subjected or not to 
a 15 min preincubation with either 300 µM imipramine or 1.5 M formamide prior to washout and then 
stained with the lipophilic dye di-4-ANEPPS. The corresponding fluorescence intensity profile in 
arbitrary units obtained along the white line on the top images are presented on the graphs bellow 
each cells. (B) Graphs showing the mean percentage of T-tubules within the cells (±SD) evaluated 
using a technique of “thresholding” and pixel counting. This allowed to calculate the percentage 
occupied by membrane within a region of interest defined inside the cell (excluding the plasma 
membrane) which is an index of the T-tubule density. The number of cells obtained from 3 rats is 
indicated on the graph. Statistical significance using a Kruskal-Wallis followed by a Dunn’s post hoc 
test was used is indicated as ***, p<0.001. 
Figure 2. Detubulation with imipramine but not with formamide preserves rod-shaped of adult 
rat ventricular myocytes. (A) Representative field area confocal images of adult rat ventricular 
myocytes subjected to a 15 min pre-incubation with a control solution without or with 300 µM 
imipramine or 1.5 M formamide prior to washout. Cells were then stained with the lipophilic dye di-
4-ANEPPS. (B) A graph showing the mean (±SD) percentage of rod-shaped cardiomyocytes is 
presented. The number of cells obtained from 3 rats is indicated on the graph. Statistical significance 
using a Chi2 test followed by a Fischer exact test is indicated as ***, p<0.001.  
Figure 3. Effect of imipramine on cell capacitance and ICa,L measured in adult rat ventricular 
myocytes. (A) The black bar represents the mean value (±SD) of cell capacitance obtained from 21 
control cardiomyocytes, the grey bar the mean capacitance of 20 cells pretreated with 300 µM 
imipramine for 15 minutes before washout. (B) L-type Ca2+ currents were elicited using the double-
pulse protocol from a holding potential of -50 mV (Inset). Superimposed recordings of ICa,L obtained 
during the pre-pulses in control or pretreated with imipramine myocytes are shown. (C) Mean 
variation (±SD) current-voltage (left panels) and steady-state inactivation (right panels) relationships 
for ICa,L in control (circles, n=21), imipramine (triangles, n=20) cardiomyocytes, These results were 
obtained in cells isolated from 5 animals. Statistical significance using an unpaired t-test is indicated 
as *, p<0.05 and ***, p<0.001 (points that occur after the time point indicated on the curves by the 
arrows are significant). 
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Figure 4. Imipramine neither affects cell capacitance nor ICa,L in rat atrial cardiomyocytes. (A) 
Mean (±SD) of cell capacitance was measured in control atrial cardiomyocytes (black bar, n=14) or 
atrial cells pre-treated with imipramine 300 µM for 15 min prior washout (grey bar, n=16). (B) Mean 
(±SD) current-voltage (left panels) and steady-state inactivation (right panels) relationships of ICa,L 
elicited using a double-pulse protocol from a holding potential of -50 mV in control (circles, n=14) 
and imipramine treated (triangles, n=16) cardiomyocytes obtained from 5 rats are shown. 
Figure 5. Imipramine does not affect the β-adrenergic stimulation of ICa,L in rat ventricular 
cardiomyocytes. (A) Superimposed recordings of ICa,L obtained during the pre-pulses in control or 
pretreated with imipramine myocytes upon β-AR stimulation by isoproterenol (Iso, 3 nM) are shown. 
(B) Mean (±SD) current-voltage and (C) steady-state inactivation (right panels) relationships of ICa,L 
elicited using a double-pulse protocol from a holding potential of -50 mV recorded in under basal 
conditions (filled symbols, n=20-21) or upon Iso (open symbols n=14-17) in control (circles) and 
imipramine treated (triangles) cardiomyocytes obtained from 5 rats are presented. Statistical 
significance using an unpaired t-test is indicated as *, p<0.05 (points that occur after the time point 
indicated on the curves by the arrows are significant). 
Figure 6. Effect of the detubulation induced by imipramine on ECC in adult rat ventricular 
myocytes. (A) Representative traces of Ca2+ transients and sarcomere shortening in Fura-2 loaded 
control or imipramine-detubulated ventricular cells paced at 1 Hz. This protocol was repeated under 
basal conditions (Ctrl), upon β-AR stimulation by isoproterenol (Iso, 3 nM). (B) Mean amplitude (±SD) 
of Ca2+ transients (upper graph) and sarcomere shortening (lower graph) in Ctrl (black bars), or 
imipramine treated cells (gray bars). (C) Average relaxation kinetics (±SD) and (D) mean (±SD) rise 
velocity of Ca2+ transients (upper graphs) and sarcomere shortening (lower graphs) (E) Proportion 
of cells exhibiting pro-arrhythmic spontaneous and asynchronous Ca2+ releases. Number of cells is 
indicated inside each bar representing the mean of 5 independent experiments. Statistical 
significance is indicated as: *, p<0.05; **, p<0.01; ***, p<0.001. A Kruskal-Wallis followed by a Dunn’s 
post hoc test was used to analyze Ca2+ transients, sarcomere amplitude. Chi2 test followed by a 
Fischer exact test to compare the percent of arrhythmic cells. 
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Figure 7. Effect of imipramine on intracellular cAMP levels upon β-adrenergic stimulation. (A) 
Representative time course of cAMP levels in a cardiomyocyte expressing the Epac-SH187 FRET-
based sensor upon a brief β-adrenergic stimulation with isoprenaline (Iso, 15s, 30 nM). CFP/YFP 
ratio was evaluated by the normalized cyan fluorescent protein (CFP) over yellow fluorescent protein 
(YFP) ratio emitted upon CFP excitation at 440±20 nM. Pseudo-color images of the CFP/YFP ratio 
were recorded at the times indicated by the letters on the graphs. Scale bar is 10 µm. (B) Mean 
(±SD) variation with time of the CFP/YFP ratio upon a pulse of Iso measured in control (circles, n=14) 
and imipramine treated (triangles, n=16) cardiomyocytes. (C) Concentration-response curves for the 
effect of isoprenaline on the CFP/YFP ratio measured in control cells (circles) and imipramine treated 
cardiomyocytes (triangles) (n=17-28). An unpaired t-test was used to test the difference in maximal 
FRET ratio variation and a F-test to compare the concentration-response curves in both conditions. 
Data represents the mean ±SD of the number of cells obtained from 5 rats. Statistical significance is 
indicated as **, p<0.01 and ***, p<0.001.  
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